Vetter’s Chicago-based manufacturing facility expansion to meet the region’s CDMO needs

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/Derek Brumby)
(Image: Getty/Derek Brumby)

Related tags: Manufacturing, facility, chicago, Early stage, CDMO, vetter

Completion of early-stage development site expansion at the Illinois Science and Technology Park supplies Chicago-based drug companies with refrigeration services for complex APIs.

The nearly complete expansion of Vetter’s clinical manufacturing facility for early-stage development will help meet the needs of its increasing customer requirements in the Midwest region, such as the complex refrigeration processes of peptides or antibodies.

Located directly outside Chicago in Skokie, IL, the offices will be complete with 45 work stations to support the increase in customer projects, and a permanent second work shift will be added to the visual inspection sector of the company. Plans of adding a second shift for quality oversight have been announced as well.

Operations at the site began in 2011 and have been continuing to grow to meet demands ever since, according to the German contract development and manufacturing organization (CDMO). The site expanded its storage capacity by 150% in 2016, additional space for storage will be completed by April including a 3100 square foot. The new storage will include a 2500 square foot freezer farm, and 600 square foot walk-in refrigerator totaling an addition of 6800 square foot.

Clauss Feussner, senior VP of Vetter development service said in a statement that expansion is part of the company’s strategic approach to focus on supplying the important service needs to its customers during their drug development journey.

A second expansion to include an additional 1,500 feet of room-temperature and freezer space is now in the planning stage. Vetter’s expansion sees the continued growth of the Illinois Science and Technology Park that was established in 2017 to provide supply to the clinical research stakeholders in Chicago and the Midwest region.

Currently, Vetter is trying to expand its footprint in its Chicago business, according to Susanne Lemaine, VP of Vetter development service Chicago, who said that the “extensive expansion​” will support the company’s evolution in the city. 

Related news

Show more

Related products

show more

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more